Matsushita Hiroshi, Tani Hirohiko
Department of Obstetrics and Gynecology Shizuoka General Hospital 4-27-1 Kitaando, Aoi-ku 420-8527 Shizuoka Japan.
Reprod Med Biol. 2011 Apr 26;10(3):193-198. doi: 10.1007/s12522-011-0083-8. eCollection 2011 Sep.
Malignant ovarian germ cell tumors (MOGCTs) are highly chemosensitive tumors most commonly found in adolescent girls and young women. However, patients with advanced disease can now be successfully cured with fertility-sparing surgery and adjuvant chemotherapy, resulting in childbearing.
A 24-year-old nulliparous Japanese woman was diagnosed as having a stage IIIc immature teratoma. After fertility-sparing surgery, she received four cycles of chemotherapy consisting of cisplatin, etoposide, and pepleomycin. She married at the age of 34, but did not conceive due to sexual dysfunction of her husband. At the age of 38, intrauterine insemination was performed following ovulation induction with clomid and human menopausal gonadotrophin, which resulted in a singleton pregnancy. A healthy female infant was delivered at 38 weeks' gestation.
Treatment might sometimes be needed for infertile women with a history of MOGCTs, but further studies are needed to determine whether infertility treatment, including ovulation induction, is appropriate.
恶性卵巢生殖细胞肿瘤(MOGCTs)是高度化疗敏感的肿瘤,最常见于青春期女孩和年轻女性。然而,患有晚期疾病的患者现在可以通过保留生育功能的手术和辅助化疗成功治愈,并实现生育。
一名24岁未生育的日本女性被诊断为IIIc期未成熟畸胎瘤。在保留生育功能的手术后,她接受了四个周期由顺铂、依托泊苷和平阳霉素组成的化疗。她34岁结婚,但由于丈夫性功能障碍未受孕。38岁时,在使用克罗米芬和人绝经期促性腺激素诱导排卵后进行了宫内人工授精,结果成功单胎妊娠。在妊娠38周时分娩出一名健康女婴。
有MOGCTs病史的不孕女性有时可能需要治疗,但需要进一步研究以确定包括诱导排卵在内的不孕治疗是否合适。